COVID-19: How R&D Responded & What We Learned for Future Outbreaks

As there is no approved treatment for COVID-19, the current standard of treatment has been to manage symptoms. Several existing and new therapies are being investigated for the treatment and prevention of COVID-19. In this Intelligence Brief, we showcase 35 and highlight 2.

Included in this Intelligence Brief:

• The latest research developments in the following areas:
  • Bioinformatics & genomics
  • Characterizing the virus
  • Vaccine development
  • Cure development
  • Drug development
• The possibility of new opportunities involving artificial intelligence

This Intelligence Brief is Part II of our 2-part series covering the COVID-19 pandemic. Part I on the epidemiology and current standard of care can be viewed here.

If you have any questions or would like to know if we can help your business with its innovation challenges, please contact us here or email us at solutions@prescouter.com.